Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Receptors, Opioid"" wg kryterium: Temat


Tytuł:
Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis.
Autorzy:
Essmat N; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1445 Budapest, Hungary.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Karádi DÁ; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1445 Budapest, Hungary.
Zádor F; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1445 Budapest, Hungary.
Király K; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1445 Budapest, Hungary.
Fürst S; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1445 Budapest, Hungary.
Al-Khrasani M; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Nagyvárad tér 4, H-1445 Budapest, Hungary.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Nov 24; Vol. 28 (23). Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Narcotic Antagonists*/therapeutic use
Opioid-Induced Constipation*/drug therapy
Humans ; Analgesics, Opioid/adverse effects ; Constipation/chemically induced ; Constipation/drug therapy ; Constipation/metabolism ; Dysbiosis/chemically induced ; Dysbiosis/drug therapy ; Receptors, Opioid/metabolism
Czasopismo naukowe
Tytuł:
Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference.
Autorzy:
Ide S; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Iwase N; UBE Corporation, Yamaguchi 755-8633, Japan.
Arai K; UBE Corporation, Yamaguchi 755-8633, Japan.
Kojima M; UBE Corporation, Yamaguchi 755-8633, Japan.
Ushiyama S; UBE Corporation, Yamaguchi 755-8633, Japan.
Taniko K; Sanwa Kagaku Kenkyusho Co., Ltd., Aichi 461-8631, Japan.
Ikeda K; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 08; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Narcotic Antagonists*/pharmacology
Opioid-Related Disorders*
Mice ; Humans ; Animals ; Morphine/pharmacology ; Naltrexone/pharmacology ; Analgesics, Opioid/pharmacology ; Receptors, Opioid, delta/metabolism ; Mice, Inbred C57BL ; Receptors, Opioid, mu/metabolism
Czasopismo naukowe
Tytuł:
Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain.
Autorzy:
El Daibani A; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Che T; Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63110, USA.; Center for Clinical Pharmacology, University of Health Sciences and Pharmacy in St. Louis, St. Louis, MO 63110, USA.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jan 18; Vol. 27 (3). Date of Electronic Publication: 2022 Jan 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Narcotic Antagonists/*pharmacology
Pain/*drug therapy
Receptors, Opioid/*chemistry
Animals ; Humans ; Ligands ; Pain/metabolism ; Pain/pathology ; Receptors, Opioid/metabolism ; Nociceptin Receptor
Czasopismo naukowe
Tytuł:
Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.
Autorzy:
Zamora JC; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Smith HR; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Jennings EM; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Chavera TS; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Kotipalli V; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Jay A; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Husbands SM; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.
Disney A; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.
Berg KA; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.; Addiction Research, Treatment & Training Center of Excellence, UT Health San Antonio, San Antonio, Texas, USA.
Clarke WP; Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.; Addiction Research, Treatment & Training Center of Excellence, UT Health San Antonio, San Antonio, Texas, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2021 Dec; Vol. 9 (6), pp. e00887.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cinnamates/*pharmacology
Morphine Derivatives/*pharmacology
Narcotic Antagonists/*pharmacology
Receptors, Opioid, mu/*antagonists & inhibitors
Allosteric Regulation/drug effects ; Animals ; Cyclic AMP/metabolism ; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology ; HEK293 Cells ; Humans ; Ligands ; Male ; Naloxone/pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, mu/metabolism ; Time Factors
Czasopismo naukowe
Tytuł:
Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice.
Autorzy:
Wang YS; Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Taiwan.
Hung TW; Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Taiwan.
Bae EK; Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Taiwan.
Wu KJ; Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Taiwan.
Hsieh W; Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Taiwan.
Yu SJ; Center for Neuropsychiatric Research, National Health Research Institute, Zhunan, Taiwan.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2021 Jul; Vol. 27 (7), pp. 831-841. Date of Electronic Publication: 2021 May 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Injuries, Traumatic/*metabolism
Brain Injuries, Traumatic/*prevention & control
Naltrexone/*therapeutic use
Narcotic Antagonists/*therapeutic use
Neuroprotective Agents/*therapeutic use
Receptors, Opioid, mu/*deficiency
Animals ; Coculture Techniques ; Male ; Mice ; Mice, Knockout ; Mice, Transgenic ; Naltrexone/pharmacology ; Narcotic Antagonists/pharmacology ; Neuroprotective Agents/pharmacology ; Receptors, Opioid, mu/antagonists & inhibitors ; Receptors, Opioid, mu/genetics
Czasopismo naukowe
Tytuł:
Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
Autorzy:
Wang H; Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, 800 E Leigh Street, Richmond, VA, 23298, USA.
Reinecke BA; Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, 800 E Leigh Street, Richmond, VA, 23298, USA.
Zhang Y; Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, 800 E Leigh Street, Richmond, VA, 23298, USA. .
Pokaż więcej
Źródło:
Journal of computer-aided molecular design [J Comput Aided Mol Des] 2020 Aug; Vol. 34 (8), pp. 879-895. Date of Electronic Publication: 2020 Mar 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Molecular Docking Simulation/*methods
Narcotic Antagonists/*chemistry
Receptors, Opioid, mu/*chemistry
Receptors, Opioid, mu/*metabolism
Allosteric Regulation ; Humans ; Isoquinolines/chemistry ; Ligands ; Molecular Dynamics Simulation ; Naltrexone/analogs & derivatives ; Narcotic Antagonists/metabolism ; Opioid-Related Disorders/drug therapy ; Protein Conformation ; Receptors, Opioid, mu/agonists ; Receptors, Opioid, mu/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice.
Autorzy:
Jacobson ML; Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA.
Wulf HA; Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA.
Browne CA; Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. .
Lucki I; Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. .; Department of Psychiatry, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2020 Dec; Vol. 237 (12), pp. 3715-3728. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Benzamides/*therapeutic use
Narcotic Antagonists/*therapeutic use
Pyrrolidines/*therapeutic use
Receptors, Opioid, kappa/*antagonists & inhibitors
Stress, Psychological/*drug therapy
Stress, Psychological/*psychology
Animals ; Benzamides/pharmacology ; Chronic Disease ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Male ; Mice ; Mice, Inbred C57BL ; Narcotic Antagonists/pharmacology ; Pyrrolidines/pharmacology ; Receptors, Opioid, kappa/physiology ; Swimming/psychology
Czasopismo naukowe
Tytuł:
Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys.
Autorzy:
Minervini V; Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive (Mail Code 7764), San Antonio, TX, 78229, USA.; Addiction Research, Treatment and Training (ARTT) Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Disney A; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
Husbands SM; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
France CP; Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive (Mail Code 7764), San Antonio, TX, 78229, USA. .; Addiction Research, Treatment and Training (ARTT) Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. .; Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2020 Oct; Vol. 237 (10), pp. 3057-3065. Date of Electronic Publication: 2020 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Cinnamates/*pharmacology
Memory/*drug effects
Morphine/*antagonists & inhibitors
Morphine/*pharmacology
Morphine Derivatives/*pharmacology
Narcotic Antagonists/*pharmacology
Receptors, Opioid, mu/*antagonists & inhibitors
Animals ; Cognition/drug effects ; Cognition/physiology ; Dose-Response Relationship, Drug ; Female ; Macaca mulatta ; Male ; Memory/physiology ; Receptors, Opioid, mu/physiology ; Reinforcement, Psychology ; Self Administration
Czasopismo naukowe
Tytuł:
Acquisition and expression of fat conditioned flavor preferences following dopamine D1, opioid and NMDA receptor antagonism in C57BL/6 mice.
Autorzy:
Iskhakova J; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Mustac T; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Yuabov A; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Macanian J; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Israel E; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Dohnalova P; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Iskhakov B; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Lulu EB; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Aminov S; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Fazylov D; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.
Bodnar RJ; Department of Psychology, Queens College, CUNY, Flushing, NY, USA.; CUNY Neuroscience Collaborative and Psychology Doctoral Program, CUNY Graduate Center, New York, NY, USA.
Pokaż więcej
Źródło:
Nutritional neuroscience [Nutr Neurosci] 2022 Jan; Vol. 25 (1), pp. 137-145. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Dietary Fats*
Narcotic Antagonists/*pharmacology
Receptors, Dopamine D1/*antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors
Taste/*physiology
Animals ; Benzazepines/pharmacology ; Conditioning, Classical ; Dizocilpine Maleate/pharmacology ; Emulsions ; Food Preferences/drug effects ; Food Preferences/physiology ; Male ; Mice ; Mice, Inbred C57BL ; Naltrexone/pharmacology ; Phospholipids ; Receptors, Opioid ; Soybean Oil ; Taste/drug effects
Czasopismo naukowe
Tytuł:
Non-Opioid Peptides Targeting Opioid Effects.
Autorzy:
Kaczyńska K; Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.
Wojciechowski P; Department of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Dec 19; Vol. 22 (24). Date of Electronic Publication: 2021 Dec 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Analgesics, Opioid/*therapeutic use
Narcotic Antagonists/*therapeutic use
Peptides/*therapeutic use
Analgesics, Opioid/pharmacology ; Animals ; Cholecystokinin/pharmacology ; Cholecystokinin/therapeutic use ; Drug Tolerance ; Ghrelin/pharmacology ; Ghrelin/therapeutic use ; Humans ; Narcotic Antagonists/pharmacology ; Oligopeptides/pharmacology ; Oligopeptides/therapeutic use ; Opioid Peptides/pharmacology ; Opioid Peptides/therapeutic use ; Peptides/pharmacology ; Receptors, Opioid/metabolism ; Nociceptin
Czasopismo naukowe
Tytuł:
Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
Autorzy:
Pergolizzi JV Jr; NEMA Research Inc, Naples, FL, USA.; Neumentum Inc, Summit, NJ, USA.; Enalare Therapeutics Inc, Princeton, NJ, USA.
Dahan A; Leiden University Medical Center, Leiden, The Netherlands.
Ann LeQuang J; NEMA Research Inc, Naples, FL, USA.
Raffa RB; Neumentum Inc, Summit, NJ, USA.; Enalare Therapeutics Inc, Princeton, NJ, USA.; College of Pharmacy (Adjunct), University of Arizona, Tucson, AZ, USA.; Temple University School of Pharmacy, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Dec; Vol. 46 (6), pp. 1501-1504. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Fentanyl/*toxicity
Naloxone/*therapeutic use
Narcotic Antagonists/*therapeutic use
Opiate Overdose/*drug therapy
Diaphragm/drug effects ; Dose-Response Relationship, Drug ; Fentanyl/pharmacology ; Heroin/toxicity ; Humans ; Laryngismus/chemically induced ; Muscle Rigidity/chemically induced ; Naloxone/pharmacology ; Narcotic Antagonists/pharmacology ; Receptors, Opioid, mu/drug effects ; Thoracic Wall/drug effects
Czasopismo naukowe
Tytuł:
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors.
Autorzy:
Wtorek K; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Adamska-Bartłomiejczyk A; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Piekielna-Ciesielska J; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Ferrari F; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44121 Ferrara, Italy.
Ruzza C; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44121 Ferrara, Italy.
Kluczyk A; Faculty of Chemistry, University of Wroclaw, 50-383 Wroclaw, Poland.
Piasecka-Zelga J; Institute of Occupational Medicine, Research Laboratory for Medicine and Veterinary Products in the GMP Head of Research Laboratory for Medicine and Veterinary Products, 91-348 Lodz, Poland.
Calo' G; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44121 Ferrara, Italy.
Janecka A; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2019 Dec 05; Vol. 24 (24). Date of Electronic Publication: 2019 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Analgesics*/pharmacology
Narcotic Antagonists*/chemistry
Narcotic Antagonists*/pharmacology
Neurokinin-1 Receptor Antagonists*/chemistry
Neurokinin-1 Receptor Antagonists*/pharmacology
Oligopeptides*/chemistry
Oligopeptides*/pharmacology
Receptors, Neurokinin-1*/agonists
Receptors, Neurokinin-1*/metabolism
Receptors, Opioid*/agonists
Receptors, Opioid*/metabolism
Nociception/*drug effects
Animals ; Cell Line ; Drug Tolerance ; Male ; Mice ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.
Autorzy:
Valenza M; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA. .
Windisch KA; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA. .
Butelman ER; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Reed B; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Kreek MJ; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue - Box 171, New York, NY, 10065, USA.
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2020 Apr; Vol. 237 (4), pp. 1147-1160. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Behavior, Addictive/*drug therapy
Brain/*drug effects
Cocaine/*administration & dosage
Cocaine-Related Disorders/*drug therapy
Narcotic Antagonists/*pharmacology
Receptors, Opioid, kappa/*antagonists & inhibitors
Animals ; Behavior, Addictive/metabolism ; Brain/metabolism ; Cocaine-Related Disorders/metabolism ; Conditioning, Operant/drug effects ; Conditioning, Operant/physiology ; Dopamine Uptake Inhibitors/administration & dosage ; Male ; Narcotic Antagonists/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, kappa/metabolism ; Self Administration ; Substance Withdrawal Syndrome/drug therapy ; Substance Withdrawal Syndrome/metabolism
Czasopismo naukowe
Tytuł:
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model.
Autorzy:
Bartlett MJ; Department of Neurology, The University of Arizona, Tucson, AZ, 85724, USA.; Department of Pharmacology, The University of Arizona, Tucson, AZ, 85724, USA.
So LY; Graduate Interdisciplinary Program in Neuroscience, The University of Arizona, Tucson, AZ, 85724, USA.
Szabò L; Department of Chemistry & Biochemistry, The University of Arizona, Tucson, AZ, 85721, USA.
Skinner DP; Department of Pharmacology, The University of Arizona, Tucson, AZ, 85724, USA.
Parent KL; Department of Chemistry & Biochemistry, The University of Arizona, Tucson, AZ, 85721, USA.
Heien ML; Department of Chemistry & Biochemistry, The University of Arizona, Tucson, AZ, 85721, USA.
Vanderah TW; Department of Pharmacology, The University of Arizona, Tucson, AZ, 85724, USA.
Polt R; Department of Chemistry & Biochemistry, The University of Arizona, Tucson, AZ, 85721, USA.
Sherman SJ; Department of Neurology, The University of Arizona, Tucson, AZ, 85724, USA.
Falk T; Department of Neurology, The University of Arizona, Tucson, AZ, 85724, USA. .; Department of Pharmacology, The University of Arizona, Tucson, AZ, 85724, USA. .; Graduate Interdisciplinary Program in Neuroscience, The University of Arizona, Tucson, AZ, 85724, USA. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2020 Mar 12; Vol. 13 (1), pp. 149. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Dyskinesia, Drug-Induced/*drug therapy
Levodopa/*adverse effects
Narcotic Antagonists/*therapeutic use
Receptors, Opioid, mu/*antagonists & inhibitors
Animals ; Disease Models, Animal ; Glycopeptides/pharmacology ; Male ; Morphine/pharmacology ; Nociception/drug effects ; Rats, Sprague-Dawley ; Receptors, Opioid, mu/metabolism
Czasopismo naukowe
Tytuł:
Effects of intracerebroventricularly administered opioid peptide antagonists on tissue glycogen levels in rats after exercise
Autorzy:
İlhan AŞ; Department of Basic Medical Sciences, Gülhane Faculty of Dentistry, University of Health Sciences, Ankara, Turkey
Güney Ş; Department of Physiology, Faculty of Medicine, Gazi University, Ankara, Turkey
Dincer S; Department of Physiology, Faculty of Medicine, Gazi University, Ankara, Turkey
Pokaż więcej
Źródło:
Turkish journal of medical sciences [Turk J Med Sci] 2021 Aug 30; Vol. 51 (4), pp. 2185-2192. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:
Journal Article
MeSH Terms:
Physical Conditioning, Animal*
Glycogen/*blood
Narcotic Antagonists/*pharmacology
Opioid Peptides/*antagonists & inhibitors
Animals ; Enkephalins/administration & dosage ; Enkephalins/pharmacology ; Infusions, Intraventricular ; Naloxone/pharmacology ; Narcotic Antagonists/administration & dosage ; Neurotransmitter Agents/administration & dosage ; Neurotransmitter Agents/pharmacology ; Opioid Peptides/administration & dosage ; Rats ; Receptors, Opioid, delta
Czasopismo naukowe
Tytuł:
Peripheral Opioid Receptor Blockade Enhances Epithelial Damage in Piroxicam-Accelerated Colitis in IL-10-Deficient Mice.
Autorzy:
Mas-Orea X; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Sebert M; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Benamar M; INFINITY, Université de Toulouse-Paul Sabatier, INSERM, CNRS, UPS, 31000 Toulouse, France.
Petitfils C; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Blanpied C; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Saoudi A; INFINITY, Université de Toulouse-Paul Sabatier, INSERM, CNRS, UPS, 31000 Toulouse, France.
Deraison C; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Barreau F; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Cenac N; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Dietrich G; IRSD, Université de Toulouse-Paul Sabatier, INSERM, INRAe, ENVT, UPS, 31000 Toulouse, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 09; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis/*metabolism
Interleukin-10/*genetics
Intestinal Mucosa/*drug effects
Naloxone/*analogs & derivatives
Narcotic Antagonists/*administration & dosage
Piroxicam/*pharmacology
Receptors, Opioid/*metabolism
Animals ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; CD4-Positive T-Lymphocytes/drug effects ; Colitis/chemically induced ; Colitis/genetics ; Colitis/pathology ; Cytokines/genetics ; Cytokines/metabolism ; Epithelial Cells/drug effects ; Inflammation/genetics ; Inflammation/metabolism ; Inflammation/pathology ; Interleukin-10/metabolism ; Intestinal Mucosa/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Naloxone/pharmacology ; Permeability/drug effects ; Quaternary Ammonium Compounds/pharmacology ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption.
Autorzy:
Nathan PJ; Experimental Medicine (Neuroscience), Sosei Heptares, Cambridge, UK.; Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, UK.; The Monash School of Psychological Sciences, Monash University, Melbourne, Australia.
Bakker G; Experimental Medicine (Neuroscience), Sosei Heptares, Cambridge, UK. .; Department of Psychiatry and Psychology, Maastricht University, Maastricht, Netherlands. .; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2021 May; Vol. 238 (5), pp. 1255-1263. Date of Electronic Publication: 2020 Jan 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Magnetic Resonance Imaging/*methods
Narcotic Antagonists/*pharmacology
Receptors, Opioid, mu/*antagonists & inhibitors
Binge-Eating Disorder/drug therapy ; Brain/drug effects ; Compulsive Behavior/drug therapy ; Humans ; Indans/pharmacology ; Obesity/physiopathology ; Triazoles/pharmacology
Czasopismo naukowe
Tytuł:
NOP receptor pharmacological profile - A dynamic mass redistribution study.
Autorzy:
Malfacini D; Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.; Section of Pharmacology, Department of Medical Sciences, and National Institute of Neurosciences, University of Ferrara, Ferrara, Italy.
Simon K; Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Trapella C; Department of Chemical and Pharmaceutical Sciences and LTTA, University of Ferrara, Ferrara, Italy.
Guerrini R; Department of Chemical and Pharmaceutical Sciences and LTTA, University of Ferrara, Ferrara, Italy.
Zaveri NT; Astraea Therapeutics, LLC, Mountain View, CA, United States of America.
Kostenis E; Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Calo' G; Section of Pharmacology, Department of Medical Sciences, and National Institute of Neurosciences, University of Ferrara, Ferrara, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Aug 30; Vol. 13 (8), pp. e0203021. Date of Electronic Publication: 2018 Aug 30 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Narcotic Antagonists/*pharmacology
Narcotics/*pharmacology
Receptors, Opioid/*metabolism
Animals ; CHO Cells ; Cricetulus ; Dose-Response Relationship, Drug ; Humans ; Ligands ; Opioid Peptides/pharmacology ; Receptors, G-Protein-Coupled/agonists ; Receptors, G-Protein-Coupled/antagonists & inhibitors ; Receptors, Opioid/agonists ; Receptors, Opioid/genetics ; Nociceptin Receptor
Czasopismo naukowe
Tytuł:
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians.
Autorzy:
Randesi M; Laboratory of the Biology of Addictive Diseases, the Rockefeller University , New York, NY, USA.
Rotrosen J; Department of Psychiatry, NYU Grossman School of Medicine , New York, NY, USA.
Nunes EV; Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center , New York, NY, USA.
Lee JD; Department of Population Health, NYU Grossman School of Medicine , New York, NY, USA.
Novo P; Department of Psychiatry, NYU Grossman School of Medicine , New York, NY, USA.
Levran O; Laboratory of the Biology of Addictive Diseases, the Rockefeller University , New York, NY, USA.
Ott J; Laboratory of Statistical Genetics, the Rockefeller University , New York, NY, USA.
Pavlicova M; Department of Biostatistics, Columbia University Mailman School of Public Health , New York, NY, USA.
Scodes J; Division of Mental Health Data Science, New York State Psychiatric Institute , New York, NY, USA.
Kreek MJ; Laboratory of the Biology of Addictive Diseases, the Rockefeller University , New York, NY, USA.
Pokaż więcej
Źródło:
The American journal of drug and alcohol abuse [Am J Drug Alcohol Abuse] 2020 Nov 01; Vol. 46 (6), pp. 761-768. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Buprenorphine, Naloxone Drug Combination/*therapeutic use
Narcotic Antagonists/*therapeutic use
Opioid-Related Disorders/*drug therapy
Receptors, Opioid/*genetics
Administration, Sublingual ; Adult ; Delayed-Action Preparations/therapeutic use ; Female ; Humans ; Injections, Intramuscular ; Male ; Middle Aged ; Naltrexone/therapeutic use ; White People/genetics
Czasopismo naukowe
Tytuł:
Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt ]DALDA (H-Dmt-D-Arg-Phe-Lys-NH 2 ).
Autorzy:
Shi S; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Xu J; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Feng L; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Fan X; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Chen Z; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Qin Y; School of Pharmacy, Nanjing Medical University, Nanjing, China.
Chung NN; Laboratory of Chemical Biology and Peptide Research, Montreal Clinical Research Institute, Montreal, QC, Canada.
Li T; School of Pharmacy, Nanjing Medical University, Nanjing, China.; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China.
Schiller PW; Laboratory of Chemical Biology and Peptide Research, Montreal Clinical Research Institute, Montreal, QC, Canada.; Department of Pharmacology and Physiology, Université de Montréal, Montreal, QC, Canada.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2020 Nov; Vol. 96 (5), pp. 1305-1314. Date of Electronic Publication: 2020 Aug 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Narcotic Antagonists/*pharmacology
Oligopeptides/*chemistry
Receptors, Opioid, mu/*antagonists & inhibitors
Animals
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies